FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Secret Service officers shoot armed individual near White House

Palisades Fire suspect was allegedly ‘fixated’ on Luigi Mangione and held ‘resentment of the rich’: court docs

Jeffries launches New York gerrymander push after redistricting clash with DeSantis

Trump Says Iran Will Be ‘Blown Off the Face of the Earth’ if They Fire on US Boats in Strait of Hormuz

Disgraced Dem cut off from doing business with government after alleged ‘outright fraud’ uncovered

Three Dead, Others Sickened in Outbreak of Rare Disease Aboard Cruise Ship

Ceasefire threatened as Iran launches waves of missiles and drones at UAE

Judge rants that Jan. 6 inmates were treated better than alleged WHCA dinner gunman

Convicted Somali scammer to avoid jail time in Minnesota’s largest-ever Medicaid fraud case

House minority leader mocks Trump with ‘Jeffries Derangement Syndrome’ jab

Schumer, Dems launch ‘free and fair’ elections task force as Trump’s SAVE America Act stumbles

FBI arrests leftist Senate hopeful for alleged death threats against Trump, Congress member and daughter

Iran Responds to Trump’s New Strait of Hormuz Plan with Aggressive Threat

Rideshare passenger held hostage for eight hours during armed standoff with police in swanky neighborhood

Breaking: ‘Project Freedom’ Leads to Immediate US Success in Strait of Hormuz

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”